GAMMA Investing’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.8M Buy
28,383
+2,538
+10% +$2.99M 1.11% 12
2026
Q2
$31M Buy
25,845
+3,238
+14% +$3.31M 1.15% 12
2026
Q1
$20.8M Buy
22,607
+786
+4% +$797K 0.97% 13
2025
Q4
$23.5M Buy
21,821
+4,641
+27% +$4.44M 1.18% 12
2025
Q3
$13.1M Sell
17,180
-804
-4% -$598K 0.72% 18
2025
Q2
$14M Sell
17,984
-16
-0.1% -$12.4K 0.89% 15
2025
Q1
$14.9M Buy
18,000
+3,696
+26% +$3.08M 1.12% 10
2024
Q4
$11M Sell
14,304
-187
-1% -$155K 0.94% 14
2024
Q3
$12.8M Buy
14,491
+2,833
+24% +$2.55M 1.27% 9
2024
Q2
$10.6M Buy
11,658
+4,853
+71% +$3.88M 1.44% 9
2024
Q1
$5.29M Buy
6,805
+960
+16% +$683K 1.08% 13
2023
Q4
$3.77M Buy
+5,845
New +$3.41M 1.02% 14

Other funds holding LLY

GAMMA Investing's LLY Position: Q3 2026 in Review

GAMMA Investing increased its Eli Lilly (LLY) stake by 9.8% in Q3 2026, buying an estimated $2.99M and bringing the position to 28,383 shares worth $32.8M. The position accounts for 1.11% of the portfolio, ranked #12.

GAMMA Investing first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 1,461 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • GAMMA Investing held 28,383 shares of Eli Lilly worth $32.8M as of Q3 2026.
  • GAMMA Investing bought 2,538 Eli Lilly shares in Q3 2026, an estimated $2.99M.
  • Eli Lilly made up 1.11% of GAMMA Investing's portfolio in Q3 2026, its #12 holding.
  • GAMMA Investing first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • 1,461 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.